amiodarone has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on this case amiodarone-related pneumonitis will be discussed, which due to a lack of pathognomonic symptoms is often difficult to diagnose and for which there are few treatment options available." | 1.35 | [Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery]. ( Fisseler-Eckhoff, A; Ghezel-Ahmadi, V; Kürschner, VC; Obenhaus, T; Schirren, J; Schmitz, JE, 2008) |
| "Amiodarone was administered to those who developed SA with a loading dose of 5 mg/kg in 30 min and a maintenance dose of 15 mg/kg in 24 h." | 1.31 | Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. ( Canneto, B; Ciriaco, P; Mazzone, P; Zannini, P, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López Brunsó, M | 1 |
| Toro Blanch, C | 1 |
| Sais Girona, E | 1 |
| Roa García, D | 1 |
| Hernández Martínez, A | 1 |
| Izquierdo Font, A | 1 |
| Guerra Prió, S | 1 |
| Mas Pueyo, HG | 1 |
| Bosch-Barrera, J | 1 |
| Ghezel-Ahmadi, V | 1 |
| Kürschner, VC | 1 |
| Fisseler-Eckhoff, A | 1 |
| Schirren, J | 1 |
| Schmitz, JE | 1 |
| Obenhaus, T | 1 |
| Tisdale, JE | 1 |
| Wroblewski, HA | 1 |
| Wall, DS | 1 |
| Rieger, KM | 1 |
| Hammoud, ZT | 1 |
| Young, JV | 1 |
| Kesler, KA | 1 |
| Ciriaco, P | 1 |
| Mazzone, P | 1 |
| Canneto, B | 1 |
| Zannini, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery[NCT00127712] | Phase 4 | 130 participants (Actual) | Interventional | 2004-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00127712)
Timeframe: 7 days
| Intervention | Participants (Number) |
|---|---|
| Amiodarone | 9 |
| Control | 22 |
(NCT00127712)
Timeframe: 7 days
| Intervention | participants (Number) |
|---|---|
| Amiodarone | 9 |
| Control | 21 |
(NCT00127712)
Timeframe: Duration of hospitalization
| Intervention | Days (Median) |
|---|---|
| Amiodarone | 7 |
| Control | 8 |
(NCT00127712)
Timeframe: Duration of hospitalization
| Intervention | Hours (Median) |
|---|---|
| Amiodarone | 46 |
| Control | 84 |
1 trial available for amiodarone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Non- | 2009 |
3 other studies available for amiodarone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Probable drug-drug interaction between erlotinib and amiodarone causes severe neurotoxicity in a patient with advanced lung cancer.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; | 2018 |
[Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; F | 2008 |
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Non-Small-Cell Lung; | 2000 |